PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
+7.24%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(+29%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
17.23%
Top 10 Holdings %
Top 10 Hldgs %
61.25%
Holding
42
New
11
Increased
10
Reduced
10
Closed
10
Top Buys
| 1 |
HNGR
Hanger Inc.
HNGR
|
$25M |
| 2 |
Zimmer Biomet
ZBH
|
$8.41M |
| 3 |
MODV
ModivCare
MODV
|
$5.73M |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$5.37M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$4.81M |
Top Sells
| 1 |
Cigna
CI
|
$10M |
| 2 |
AGN
Allergan plc
AGN
|
$7.68M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
$6.56M |
| 4 |
Cidara Therapeutics
CDTX
|
$3.67M |
| 5 |
MacroGenics
MGNX
|
$3.45M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
1
DELISTED
Hanger Inc.
HNGR
| $25M | 13.93% | +1,199,602 | New | +$25M |
|
|
TLGT
2
DELISTED
Teligent, Inc
TLGT
| $12.8M | 7.14% | 3,240,761 -84,239 | -3% | -$333K |
|
|
ARNA
3
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.2M | 6.26% | 244,050 +104,522 | +75% | +$4.81M |
|
|
4
MacroGenics
MGNX
$112M
| $9.81M | 5.47% | 457,475 -161,040 | -26% | -$3.45M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.35M | 5.21% | 96,428 +38,528 | +67% | +$3.74M |
|
|
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $9.31M | 5.19% | 1,661,940 +301,940 | +22% | +$1.69M |
|
|
7
Zimmer Biomet
ZBH
$21B
| $8.41M | 4.69% | +63,930 | New | +$8.41M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $8.05M | 4.49% | 715,317 +275,417 | +63% | +$3.1M |
|
9
Indaptus Therapeutics
INDP
$7.19M
| $7.56M | 4.21% | 1,337,191 +212,038 | +19% | +$1.2M |
|
|
RETA
10
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.55M | 3.65% | 80,155 -2,939 | -4% | -$240K |
|
|
11
Cigna
CI
$80.3B
| $6.09M | 3.39% | 29,236 -48,164 | -62% | -$10M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $5.98M | 3.34% | 31,400 -40,300 | -56% | -$7.68M |
|
|
MODV
13
DELISTED
ModivCare
MODV
| $5.73M | 3.2% | +85,217 | New | +$5.73M |
|
|
ALBO
14
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $5.37M | 2.99% | +162,905 | New | +$5.37M |
|
15
Viking Therapeutics
VKTX
$3.04B
| $4.78M | 2.67% | +274,410 | New | +$4.78M |
|
|
SRRA
16
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.62M | 2.58% | 2,720,089 +913,527 | +51% | +$1.55M |
|
17
Assembly Biosciences
ASMB
$190M
| $4.44M | 2.48% | 119,578 +54,277 | +83% | +$2.02M |
|
18
Kura Oncology
KURA
$686M
| $4.44M | 2.48% | 253,631 -34,256 | -12% | -$600K |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $4.24M | 2.37% | 23,400 -8,600 | -27% | -$1.56M |
|
|
EIGR
20
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.1M | 2.28% | 341,457 -96,965 | -22% | -$1.16M |
|
21
Centene
CNC
$14.3B
| $2.88M | 1.6% | 19,875 +9,000 | +83% | +$1.3M |
|
22
Axogen
AXGN
$743M
| $2.83M | 1.58% | +76,741 | New | +$2.83M |
|
23
Evolus
EOLS
$494M
| $2.58M | 1.44% | +138,460 | New | +$2.58M |
|
24
Gyre Therapeutics
GYRE
$703M
| $2.55M | 1.42% | +236,558 | New | +$2.55M |
|
|
SBBP
25
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.06M | 1.15% | +423,846 | New | +$2.06M |
|